ARCHIVES

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI CTEP Last Month

July 29, 2011

Herceptin Reduces Recurrence In Early HER2+ Breast Cancer

September 30, 2005

“5 A Day” Review Underway to Check Program’s Health at NCI.

March 31, 2000

Program Project Guidelines Listed

March 18, 1977

Adding Aresenic To Therapy Improves APL Survival

July 27, 2007

A Conversation With Daniel Masys: Acronym “CABIG” Could Be Eliminated

January 6, 2012